Canada: Proposed Revisions To The CCB's Immunity Program: Minor Recalibration Or Significant Shift?

Last Updated: February 2 2018
Article by Huy A. Do and Justine Reisler

On October 26, 2017, the Canadian Competition Bureau ("Bureau") released for public comment a revised version of its Immunity Program, under which a party may receive immunity from criminal prosecution if the party is the first to disclose an offence and agrees to cooperate with the Bureau's investigation and prosecution of others. The revisions, discussed below, has led to comments and concerns from, among others, the CBA National Competition Law Section and the ABA Section of Antitrust Law. These comments and concerns are discussed below.

According to the press release, the program is being updated to increase transparency and predictability in light of legal and policy developments.

The Bureau has advised that the changes are prompted partly by the outcome of recent unsuccessful prosecutions and include the following:

  • Interim Grant of Immunity: Documentary and testimonial evidence will be provided under an interim grant of immunity (IGI). Final immunity will be provided when the applicant's cooperation and assistance is no longer required.
  • End of Automatic Corporate Immunity for Directors, Officers and Employees: Automatic coverage under a corporate immunity agreement for all directors, officers and employees will no longer be provided. Instead, individuals that require immunity will need to demonstrate their knowledge of the conduct in question and their willingness to cooperate with the Bureau's investigation.
  • Greater Use of Recordings: Witness interviews may be conducted under oath and may be video or audio recorded. Proffers, statements made by an applicant (usually through counsel) to the Bureau where the applicant is expected to reveal its identity and describe in detail the anti-competitive activity, may also be audio recorded.
  • Privileged Documents: Non-privileged records from companies' internal investigations will be treated as presumptively disclosable facts in the possession of cooperating parties. And while privileged records will continue to be protected from disclosure, applicants will now be required to justify their claims of privilege.

Although billed as uncontroversial changes, the draft revisions arguably adds to the burden on, and costs to, prospective immunity applicants, raising questions of whether this may lead to less self-reporting and undermine the effectiveness of the program.

CBA Comments

The Competition Law Section of the Canadian Bar Association released comments on the Competition Bureau's Proposed Revisions to the Immunity Program on January 22, 2018 The CBA Section is of the view that the existing program is working well and does not need the fundamental overhaul proposed.

The CBA Section expressed serious concerns about the nature and substance of many of the proposed revisions to the Program. The changes could add significant burdens and uncertainties on immunity applicants in Canada which are inconsistent with existing leniency and amnesty programs available in other jurisdictions. The CBA Section believes that an immunity applicant should not be placed at a distinct disadvantage relative to non-cooperating parties, particularly in responding to anticipated civil litigation. But most importantly, the CBA asserts, the proposed changes would undermine incentives to self-report.

The CBA Section raised concerns with the following specific proposed changes to the Immunity Program:

  • Proposed Obligation to Produce "Credible and Reliable Evidence": Applicants typically seek immunity shortly following the discovery of potentially criminal conduct; at that time, applicants are not able to assess whether the information they have is credible or reliable. Under this proposed change, the prospective immunity applicant would presumably have to weigh and assess the credibility and reliability of its witnesses prior to seeking a marker throughout the process. The Section is of the view that this proposal would add to the uncertainties of the process and create disincentives for self-reporting.
  • Proposed Elimination of the Paperless Proffer Process: The paperless process had the benefits of contributing to the speed and timeliness of the immunity process in Canada and it is similar to the process used in the US. Replacing verbal proffers with electronic audio recording of proffers would require more time and effort in the preparation of proffers, increasing the cost on applicants participating in the program. While the lawyer's proffer has no evidentiary value in the context of a criminal prosecution, it may have significant value to a private plaintiff in a class proceeding, further increasing the costs and risks of self-reporting.
  • Proposal to Record Witness Interviews: The proposal that witness interviews may be taken under oath and may be video and/or audio recorded could create significant new exposures for applicants (particularly in civil proceedings) and as a result, may make the applicant worse-off for choosing to cooperate with the Bureau.
  • Proposed Changes for an Interim Grant of Immunity ("IGI"): The proposed IGI process creates new uncertainties, by pushing the timeline for the applicant to receive a binding immunity agreement into the distant future.
  • Proposed Protocol for Reviewing and Adjudicating Privilege Claims by Immunity Applicants: The proposed protocol needs to firmly and clearly support the ability of an applicant to assert privilege over the investigative work product of its external counsel. The protocol lacks some basic elements of due process necessary for adjudicating privilege claims in Canada including the fact that the adjudicator would be appointed from a list of Crown agents raising institutional independence and impartiality concerns. The proposed consequences for failing to comply with the protocol – cancellation of a marker or denial of a grant of immunity – are unfair. Furthermore, this proposal is inconsistent with the approach other antitrust regulators.

The CBA Section believes that these proposed revisions would undermine the goal of effective criminal enforcement in Canada and are encouraging the Bureau to reconsider them.

ABA Comments

The Sections of Antitrust Law and International Law of the American Bar Association ("ABA") released their comments on the Bureau's Draft Immunity Program on January 19, 2018. The Sections expressed concern especially with the speed at which the immunity process will unfold and the incentives for applicants to participate in the program. The Sections are of the view that it takes too long for the Bureau and the DPP to grant immunity (or some confirmation that immunity will be recommended) to willing applicants. In the lengthy interim period, the applicant is exposed to prosecution risk and must incur significant expense in the process, echoing the concerns of the CBA.

The sections expressed concern about a number of specific proposed changes and made suggestions for improvement, including the following,:

  • Two-Stage IGI Process: The two-stage IGI process would unnecessarily impede and possibly discourage applicants from seeking immunity in Canada. The Sections suggest that the Bureau clarify that the IGI is a three-party agreement between the applicant, the Bureau and the DPP. They also suggest that the standards by which an applicant's cooperation is to be assessed. And the Sections recommend that the DPP should use the same standards as the Bureau and should make that commitment in writing.
  • Extensive Information Requirements to be addressed in Proffers: The proposed requirement by the Bureau that the applicant provide exhaustive information relating to the list of topics to be covered by the attorney and the initial witness proffers is too burdensome. The Sections recommend a far more collaborative process between the Bureau in the DPP at an earlier stage.
  • Mandatory Confidentiality Waivers Related to Cooperation with Foreign Antitrust Authorities: The Sections advise against such mandatory waiver requirements, which are counter to the entire confidential process of immunity and leniency programs throughout the world. Immunity works because it is confidential. This proposal puts the applicant at risk of violating confidentiality policies of other countries and could expand the scope of the company's investigative exposure. Applicants should not be made worse off as a result of the application.
  • Moving away from a Paperless Application Process: The Sections are particularly concerned with the proposals to record attorney proffers and more frequent and earlier use of recorded witness interviews. This is because one of the greatest costs that a corporation must consider in deciding whether to pursue immunity and thus expose a cartel is the high probability that its decision to do so will precipitate civil damages. There is uncertainty in the US over whether materials prepared specifically for the immunity or leniency process are discoverable and thus can be used by plaintiffs as evidence in civil actions.
  • Privileged Records: The Sections expressed concern with the proposed regime for review of certain privileged records (particularly if this were to be applied beyond records that were contemporaneous with the alleged offences and, and to include attorney work product and privileged attorney investigations of potentially problematic conduct), especially if it is to be used frequently.

Still to Come – Revisions to the Leniency Program>

The Bureau has also indicated that there will also be changes coming to its Leniency Program (which incentivize parties who are too late to obtain immunity to cooperate with the Bureau and plead guilty in exchange for lenient treatment, including a reduction in the fines). The Bureau expects to circulate a draft of the revised program for public consultation soon. An expected change to the Leniency Program includes all leniency applicants being potentially eligible for fine discounts of up to 50% (thereby moving toward a system of rewarding applicants based on the value of their cooperation rather than who is first to contact the agency for leniency).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions